Patents/Assignees

Chugai Seiyaku Kabushiki Kaisha

124 patents in portfolio

US12371511utility2025
Heterodimerized Polypeptide
0 cites
US12365682utility2025
Process to Make GLP1 RA and Intermediates Therefor
0 cites
US12359001utility2025
Method for Producing Polypeptide Hetero-oligomer
0 cites
US12344859utility2025
Method of Introducing Target-specific Foreign Gene
0 cites
US12331049utility2025
Pyrazolopyridine Derivative Having GLP-1 Receptor Agonist Effect
0 cites
US12331050utility2025
Pyrazolopyridine Derivative Having GLP-1 Receptor Agonist Effect
0 cites
US12331072utility2025
Deprotection Method and Resin Removal Method in Solid-phase Reaction for Peptide Compound or Amide Compound, and Method for Producing Peptide Compound
0 cites
USRE050455reissue2025
Pyrazolopyridine Derivative Having GLP-1 Receptor Agonist Effect
0 cites
US12312379utility2025
Methods for Producing Cyclic Compounds Comprising N-substituted Amino Acid Residues
0 cites
US12312297utility2025
O-substituted Serine Derivative Production Method
0 cites
US12304960utility2025
Anti-cd137 Antigen-binding Molecule and Utilization Thereof
0 cites
US12281141utility2025
Method for Synthesizing Peptide Containing N-substituted Amino Acid
0 cites
US12269876utility2025
Modified Fc Region of Antibody
0 cites
US12258162utility2025
Filling Nozzle
0 cites
US12252532utility2025
Anti-myostatin Antibodies and Methods of Use
0 cites
US12234573utility2025
Library of Antigen-binding Molecules Including Modified Antibody Variable Region
0 cites
US12235261utility2025
Method for Measuring Cellular Uptake of Molecules
0 cites
US12209121utility2025
Anti-sclerostin Antibodies and Methods of Use
0 cites
US12195528utility2025
Ligand-binding Molecule Having Adjustable Ligand-binding Activity
0 cites
US12187724utility2025
Pyrazolopyridine Derivative Having GLP-1 Receptor Agonist Effect
0 cites

← PreviousPage 3 of 7Next →